EUCTR2008-008367-95-SE进行中（未招募）不适用
Effect of exenatid on microcirculation in patients with type 2 diabetes mellitus and coronary artery disease
Karolinska Institutet, Inst för kliniska vetenskaper, Danderyds sjukhus0 个研究点目标入组 60 人开始时间: 2009年2月12日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Type 2 diabetes mellitus
- •2.Treatment with Metformin and/or SU at least 3 months prior to randomisation
- •3.Glycated haemoglobin >6.0%
- •4.Coronary artery disease, i.e. previous MI, stable angina, acute coronary syndrome
- •5.Signed written inform consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Age >75 or <18 years
- •2.Glycated haemoglobin >10%
- •3.Childbearing potential
- •4.Impaired renal function with creatinine clearance <30 ml/min
- •5.Current or previous treatment with exenatid
- •6.Current insulin use
- •7.Any concomitant disease or condition that may interfere with the possibility for the patient to comply with or complete the study protocol
- •8.Participant in an ongoing study
研究者
相似试验
已完成
不适用
Effects of exenatide on postprandial vascular endothelial function in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000015699First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health15
进行中（未招募）
不适用
Cardiovascular fysiological effects of Exenatide on heart failureEUCTR2006-005220-16-SEKarolinska institutet
进行中（未招募）
不适用
Effect of Aliskiren drug in patients with high blood pressuredysfunction of coronary microcirculation in arterial hypertensionMedDRA version: 14.1Level: HLTClassification code 10010164Term: Hypertension complicationsSystem Organ Class: 10047065 - Vascular disordersEUCTR2011-002587-24-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
进行中（未招募）
1 期
Exenatide Treatment in Parkinson's DiseaseParkinson's diseaseEUCTR2019-000732-26-SEStockholm Health Care Services60
进行中（未招募）
不适用
Effects of Exenatide (Byetta®) on biochemical and histological parameters of liver function in patients with Nonalcoholic Steatohepatitis (NASH) – a randomized, placebo-controlled, parallel-group trialon alcoholic steatohepatitis (NASH)MedDRA version: 9.1Level: LLTClassification code 10053219Term: Non-alcoholic steatohepatitisEUCTR2008-002325-37-DEDepartment of Medicine I, University Hospital St. Josef-Hospital, Ruhr University Bochum